ANGUS ACQUIRES EXPRESSION SYSTEMS, LLC

ANGUS Chemical Company

PR98730

 

BUFFALO GROVE, Ill. and DAVIS, Calif., Nov. 10, 2022 /PRNewswire=KYODO JBN/ --

 

-- Expression Systems is a leading supplier of innovative cell culture media,

baculovirus molecular reagents and cell lines used in advanced biological-based

therapeutics

 

ANGUS Chemical Company ("ANGUS" or "Company"), a leading global manufacturer

and marketer of specialty ingredients for Life Sciences and Industrial markets,

today announced it has acquired Expression Systems, LLC (

https://c212.net/c/link/?t=0&l=en&o=3703648-1&h=2194462671&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3703648-1%26h%3D2373763013%26u%3Dhttps%253A%252F%252Fexpressionsystems.com%252F%26a%3DExpression%2BSystems%252C%2BLLC&a=Expression+Systems%2C+LLC

) ("Expression Systems"), a leading global manufacturer of cell culture media

and related products and services. ANGUS is a portfolio company of Ardian and

Golden Gate Capital.

 

Logo - https://mma.prnewswire.com/media/460234/ANGUS_Chemical_Company_Logo.jpg

 

Founded in 1997, Expression Systems is dedicated to supplying and servicing the

baculovirus expression platform with innovative cell culture media

formulations, as well as cell lines, molecular tools, reagents and contract

services. Expression Systems operates from a central headquarters in Davis,

California, and is cGMP-compliant and ISO 13485 certified for its manufacturing

and research activities.

 

"The acquisition of Expression Systems is an important step in expanding ANGUS'

leadership position in Life Sciences beyond bio buffers into specialty cell

culture media, a strategic adjacency with high customer overlap and

complementary product and service offerings," said ANGUS President and Chief

Executive Officer David Neuberger. "The combination of ANGUS and Expression

Systems further strengthens our ability to deliver value through the

consistent, high-quality ingredients and services essential to all phases of

bioprocessing, from early-stage biologics development to full-scale commercial

production."

 

Expression Systems is a well-recognized independent provider of specialized

cell culture media and related products with a robust track record of product

quality and innovation based on proprietary technology. The company specializes

in baculovirus expression vector system (BEVS) and has deep expertise across

the process from gene optimization to protein purification. Expression Systems'

products are utilized primarily by structural biology researchers and biologics

manufacturers to produce certain drug candidates, protein-based therapies,

vaccines and gene therapies efficiently and cost-effectively.

 

"For more than 20 years, our family and dedicated employees have built a strong

reputation with its customers by leveraging our world-renowned technical

expertise in media manufacturing and the baculovirus expression platform," said

Expression Systems President and Chief Executive Officer David Hedin. "When we

looked ahead to the future for our company, it was clear that ANGUS was in the

best position to provide new opportunities to our current and new customers, as

well as our employees. ANGUS will enhance our position as a dedicated,

world-leading vendor focused on servicing the biologics industry segments

employing the baculovirus expression platform."

 

Achelous Partners, LLC served as exclusive M&A advisor to Expression Systems,

LLC on this transaction.

 

ABOUT ANGUS

 

ANGUS is a leading global manufacturer and marketer of specialty ingredients

and consumables for biotechnology, pharmaceutical, consumer and industrial

applications. The Company innovates through its unique nitroalkane chemistries,

including its flagship AMP(TM) (aminomethyl propanol) multifunctional additives

and TRIS AMINO(TM) (tromethamine) buffers, which are produced at fully

integrated, ISO 9001-certified manufacturing facilities in the United States

and Germany. ANGUS serves its global customers through six regional Customer

Application Centers located in Chicago, Illinois; Paris, France; Sao Paulo,

Brazil; Singapore; Shanghai, China; and Mumbai, India. The Company is privately

owned by Ardian and Golden Gate Capital, and is headquartered in Buffalo Grove,

Illinois. For more information, visit angus.com (

https://c212.net/c/link/?t=0&l=en&o=3703648-1&h=1106554617&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3703648-1%26h%3D4165547409%26u%3Dhttp%253A%252F%252Fwww.angus.com%252F%26a%3Dangus.com&a=angus.com

).

 

Follow ANGUS on Facebook (

https://c212.net/c/link/?t=0&l=en&o=3703648-1&h=69182100&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3703648-1%26h%3D1132377599%26u%3Dhttps%253A%252F%252Fwww.facebook.com%252FANGUSChemCo%26a%3DFacebook&a=Facebook

), Twitter (

https://c212.net/c/link/?t=0&l=en&o=3703648-1&h=8552847&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3703648-1%26h%3D634416664%26u%3Dhttps%253A%252F%252Ftwitter.com%252Fanguschemco%26a%3DTwitter&a=Twitter

), and LinkedIn (

https://c212.net/c/link/?t=0&l=en&o=3703648-1&h=2011470375&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3703648-1%26h%3D2547257105%26u%3Dhttp%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fangus-chemical-company%26a%3DLinkedIn&a=LinkedIn

).

 

FOR ADDITIONAL INFORMATION

ANGUS Media Relations

Scott C. Johnson

+1 847-808-3769

scjohnson@angus.com

 

SOURCE: ANGUS Chemical Company

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中